etodolac has been researched along with Angiogenesis, Pathologic in 3 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When tumors reached 100 mm, mice were treated with CpG-C/vehicle, and 24 hours later the tumor was excised along with P+E/vehicle treatment." | 1.37 | Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. ( Ben-Eliyahu, S; Benish, M; Goldfarb, Y; Levi, B; Melamed, R; Sorski, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldfarb, Y | 1 |
| Sorski, L | 1 |
| Benish, M | 1 |
| Levi, B | 1 |
| Melamed, R | 1 |
| Ben-Eliyahu, S | 1 |
| Hasegawa, K | 1 |
| Ohashi, Y | 1 |
| Ishikawa, K | 1 |
| Yasue, A | 1 |
| Kato, R | 1 |
| Achiwa, Y | 1 |
| Nishio, E | 1 |
| Udagawa, Y | 1 |
| Sugihara, I | 1 |
| Yoshida, M | 1 |
| Shigenobu, T | 1 |
| Takagi, H | 1 |
| Maruyama, K | 1 |
| Takeuchi, N | 1 |
| Toda, M | 1 |
| Inoue, M | 1 |
| Nakada, H | 1 |
3 other studies available for etodolac and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Topics: Analysis of Variance; Animals; Chemotherapy, Adjuvant; Disease Models, Animal; Etodolac; Female; Imm | 2011 |
Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
Topics: Cell Cycle; Cell Cycle Proteins; Chemoprevention; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygen | 2005 |
Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 | 2006 |